Prediction of cardiovascular events after renal transplantation

F S Seibert1, C Behrendt2, N Pagonas1

  • 1Universitätsklinikum Marien Hospital Herne, Ruhr-University Bochum, Medizinische Klinik I, Herne, Germany; Charité - Campus Benjamin Franklin, Department of Nephrology, Berlin, Germany.

Insights

Pulse wave velocity (PWV), a measure of arterial stiffness, significantly predicts cardiovascular events in renal transplant recipients. This finding highlights PWV as a crucial indicator for cardiovascular risk in this patient population.

Area of Science:

  • Cardiology
  • Nephrology
  • Vascular Medicine

Background:

  • Cardiovascular events (CVE) are a primary cause of mortality and graft loss in renal transplant recipients.
  • Pulse wave velocity (PWV) is a recognized indicator of arterial stiffness and a predictor of CVE in the general population.
  • The relationship between PWV and CVE in renal transplant recipients requires further investigation.

Purpose of the Study:

  • To investigate the correlation between pulse wave velocity (PWV) and the occurrence of cardiovascular events (CVE) in stable renal transplant recipients.
  • To determine if arterial stiffness, measured by PWV, is a significant predictor of adverse cardiovascular outcomes in this specific patient group.

Main Methods:

  • A prospective study involving 64 stable renal transplant recipients was conducted over a minimum of 3 years.
  • Pulse wave velocity (PWV), augmentation index (AI75), and central aortic systolic pressure were measured using the SphygmoCor device.
  • A composite endpoint included death, myocardial infarction, stroke, or hospitalization for intermittent claudication or heart failure.

Main Results:

  • During a 4.4-year follow-up, 15 patients (23%) experienced a composite cardiovascular endpoint.
  • Pulse wave velocity (PWV) was significantly associated with the occurrence of cardiovascular events (P = .048).
  • Patients who reached the endpoint exhibited higher mean PWV values (10.1 ± 3.6 m/s) compared to those who did not (8.5 ± 1.5 m/s).

Conclusions:

  • Increased arterial stiffness, as indicated by elevated PWV, is a significant predictor of cardiovascular events in renal transplant recipients.
  • PWV may serve as a valuable biomarker for accelerated arteriosclerosis in patients who have undergone kidney transplantation.
  • Assessing PWV could aid in risk stratification and management of cardiovascular disease in renal transplant recipients.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
765
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
518
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
861
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
596
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.0K
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
322